Technology News and Research

RSS

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) announced today an innovative program aimed at improving the treatment of type 1 diabetes by developing novel insulin delivery products to enhance the use of insulin pumps.

From BD (Becton, Dickinson and Company) 20 Jan 2010

Liquidia Technologies completes $20M Series C financing round

Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.

20 Jan 2010

Patient enrollment for Phase 2B clinical study of Oramed Pharmaceuticals' ORMD-0801 completed

Oramed Pharmaceuticals Inc. announced today the completion of patient enrollment in the Phase 2B clinical study of its oral insulin capsule, ORMD-0801.

20 Jan 2010

Neomend receives premarket approval from FDA for ProGEL Pleural Air Leak Sealant

Neomend, Inc., an innovator in sealant and adhesion-prevention products for the surgical marketplace, announced it has received premarket approval from the U.S. Food and Drug Administration (FDA) for the company’s ProGEL™ Pleural Air Leak Sealant.

20 Jan 2010

HTDS announces possible merger with EU-based, stem-cell research company

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica BioChem want to point the shareholders back to the press release from Oct 29, 2009, where the company announced news about a possible merger with a EU based, stem-cell research company.

20 Jan 2010

Fraunhofer USA CMB receives $60,000 gift from ProTecs to complete vaccine manufacturing plant

The Fraunhofer USA Center for Molecular Biotechnology, a not-for-profit, 501 (c3) research organization, announced today that it has received a $60,000 gift from ProTecs, Inc., to complete its new, state of-the-art vaccine manufacturing plant in Newark, Delaware.

20 Jan 2010

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

Sangamo BioSciences, Inc. announced today that preliminary data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were presented on Friday, January 15, 2010 at the Keystone Symposium Session "HIV Biology and Pathogenesis."

20 Jan 2010

SRA International awarded MARCS Integration Contract

SRA International, Inc., a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced that, on behalf of the Food and Drug Administration (FDA), the Department of the Interior/National Business Center/Acquisition Services Directorate-Herndon has awarded SRA the Mission Accomplishment and Regulatory Compliance Services (MARCS) Integration Contract (MIC).

19 Jan 2010

World Heart's Levacor VAD implant performed at INTEGRIS Baptist Medical Center

World Heart Corporation ("WorldHeart"), a developer of mechanical circulatory systems, announced today that the first U.S. implant of the Levacor Ventricular Assist Device ("VAD") was successfully performed at INTEGRIS Baptist Medical Center ("INTEGRIS") in Oklahoma City on Wednesday, January 13, 2010.

19 Jan 2010

Corventis' NUVANT MCT System for detecting non-lethal arrhythmias receives FDA marketing clearance

Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.

19 Jan 2010

Novartis obtains exclusive worldwide rights to develop and commercialize Chiasma's TPE technology

Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.

19 Jan 2010

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

GenVec and Novartis will collaborate to discover and develop novel treatments for hearing loss and balance disorders. Preclinical results suggest that delivery of the atonal gene using GenVec's innovative adenovector technology may have the potential to restore hearing and balance function.

19 Jan 2010

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of “digital proteomics” with next generation sequencers. One of the nation’s top cancer research and treatment centers, City of Hope is a leading provider of molecular diagnostic testing services and an innovator in clinical genetics research.

19 Jan 2010

Surrex Consulting launches new division created to service the Healthcare IT and EHR market

Surrex Consulting, a nationwide provider of Information Technology (IT) Staffing and Consulting Services, today announced the launch of a new division created to service the Healthcare IT and Electronic Health Records (EHR) market.

19 Jan 2010

Medpro Safety Products purchases product development rights from Visual Connections

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection systems, has purchased product development rights for a unique, fully passive Insulin Guard self-injector from Visual Connections, owned by Hooman Asbaghi. Mr. Asbaghi is the inventor of MedPro’s fully passive phlebotomy collection devices, which include two versions of a safety blood collection holder, a passive IV catheter, and a safety blood collection set.

19 Jan 2010

Stratasys signs definitive agreement with HP to manufacture 3D printers using its patented FDM technology

Stratasys, Inc., the leading manufacturer of 3D printers and 3D production systems, today announced it has signed a definitive agreement with HP for Stratasys to manufacture an HP-branded 3D printer.

19 Jan 2010

Molina Healthcare enters into definitive agreement to acquire HIM business of Unisys

Molina Healthcare, Inc. today announced that it has entered into a definitive agreement to acquire the Health Information Management (HIM) business of Unisys Corporation.

19 Jan 2010

IBM unveils new initiative to generate measurable business results

IBM today unveiled a new initiative to help clients increase the speed of business and improve results through collaboration technology and industry expertise. IBM's Collaboration Agenda brings together IBM's vertical industry expertise, software lab specialists and consulting services experts to help clients realize measurable returns from improving the way people interact.

19 Jan 2010

Study reveals declining employer satisfaction with health insurers

Employers in the United States have become less satisfied with their health insurers, according to a study released today by PricewaterhouseCoopers' Health Research Institute. Hit hard by the recession, employers of all sizes are taking a critical look at their health benefits strategy and the value they derive from it. They are looking to their health plan providers for information, technology and strategies to help reduce waste in healthcare spending and better engage employees in managing their health.

19 Jan 2010

Circassia commences Phase II trials of its T-cell vaccines against house dust mite and cat allergies

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.

19 Jan 2010

Technology News and Research

JDRF and BD join to develop novel insulin delivery products for treatment of type 1 diabetes

Liquidia Technologies completes $20M Series C financing round

Patient enrollment for Phase 2B clinical study of Oramed Pharmaceuticals' ORMD-0801 completed

Neomend receives premarket approval from FDA for ProGEL Pleural Air Leak Sealant

HTDS announces possible merger with EU-based, stem-cell research company

Fraunhofer USA CMB receives $60,000 gift from ProTecs to complete vaccine manufacturing plant

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

SRA International awarded MARCS Integration Contract

World Heart's Levacor VAD implant performed at INTEGRIS Baptist Medical Center

Corventis' NUVANT MCT System for detecting non-lethal arrhythmias receives FDA marketing clearance

Novartis obtains exclusive worldwide rights to develop and commercialize Chiasma's TPE technology

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Surrex Consulting launches new division created to service the Healthcare IT and EHR market

Medpro Safety Products purchases product development rights from Visual Connections

Stratasys signs definitive agreement with HP to manufacture 3D printers using its patented FDM technology

Molina Healthcare enters into definitive agreement to acquire HIM business of Unisys

IBM unveils new initiative to generate measurable business results

Study reveals declining employer satisfaction with health insurers

Circassia commences Phase II trials of its T-cell vaccines against house dust mite and cat allergies

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News